BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 15573772)

  • 1. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
    Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
    Bofin AM; Lydersen S; Hagmar BM
    Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions.
    MacGrogan G; Arnould L; de Mascarel I; Vincent-Salomon A; Penault-Llorca F; Lacroix-Triki M; Bibeau F; Baranzelli MC; Fridman V; Antoine M; Bécette V; Brouste V; Jacquemier J; Mathoulin-Pélissier S;
    Histopathology; 2008 May; 52(6):689-97. PubMed ID: 18397281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
    Piubello Q; Montemezzi S; D'Atri C
    Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Borderline breast lesions: diagnostic challenges and clinical implications.
    Masood S; Rosa M
    Adv Anat Pathol; 2011 May; 18(3):190-8. PubMed ID: 21490436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Training and standardized criteria improve the diagnosis of premalignant breast lesions].
    Salles Mde A; Gouvêa AP; Savi D; Figueiredo MA; Tavares Neto R; Paula RA; Gobbi H
    Rev Bras Ginecol Obstet; 2008 Nov; 30(11):550-5. PubMed ID: 19148432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillary lesions of the breast: impact of breast pathology subspecialization on core biopsy and excision diagnoses.
    Jakate K; De Brot M; Goldberg F; Muradali D; O'Malley FP; Mulligan AM
    Am J Surg Pathol; 2012 Apr; 36(4):544-51. PubMed ID: 22314186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypia on breast core needle biopsies: reproducibility and significance.
    Darvishian F; Singh B; Simsir A; Ye W; Cangiarella JF
    Ann Clin Lab Sci; 2009; 39(3):270-6. PubMed ID: 19667411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological diagnosis of columnar cell lesions of the breast: are there issues of reproducibility?
    Tan PH; Ho BC; Selvarajan S; Yap WM; Hanby A
    J Clin Pathol; 2005 Jul; 58(7):705-9. PubMed ID: 15976336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast pathology practice: most common problems in a consultation service.
    Putti TC; Pinder SE; Elston CW; Lee AH; Ellis IO
    Histopathology; 2005 Nov; 47(5):445-57. PubMed ID: 16241992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant breast lesions that may mimic benign tumors.
    Weidner N
    Semin Diagn Pathol; 1995 Feb; 12(1):2-13. PubMed ID: 7770672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interobserver agreement of a probabilistic approach to reporting breast fine-needle aspirations on ThinPrep.
    Gornstein B; Jacobs T; Bédard Y; Biscotti C; Ducatman B; Layfield L; McKee G; Sneige N; Wang H
    Diagn Cytopathol; 2004 Jun; 30(6):389-95. PubMed ID: 15176025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria.
    Schnitt SJ; Connolly JL; Tavassoli FA; Fechner RE; Kempson RL; Gelman R; Page DL
    Am J Surg Pathol; 1992 Dec; 16(12):1133-43. PubMed ID: 1463092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudoangiomatous stromal hyperplasia of the breast: a contemporary approach to its clinical and radiologic features and ideal management.
    Gresik CM; Godellas C; Aranha GV; Rajan P; Shoup M
    Surgery; 2010 Oct; 148(4):752-7; discussion 757-8. PubMed ID: 20708765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 12 strategies for obtaining second opinions to improve interpretation of breast histopathology: simulation study.
    Elmore JG; Tosteson AN; Pepe MS; Longton GM; Nelson HD; Geller B; Carney PA; Onega T; Allison KH; Jackson SL; Weaver DL
    BMJ; 2016 Jun; 353():i3069. PubMed ID: 27334105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of three classification systems of ductal carcinoma in situ of the breast using a web-based survey.
    Schuh F; Biazús JV; Resetkova E; Benfica CZ; Edelweiss MI
    Pathol Res Pract; 2010 Oct; 206(10):705-11. PubMed ID: 20663616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic immunohistochemistry of breast epithelial lesions].
    Balaton AJ; Guinebretière JM; Penault-Llorca F
    Ann Pathol; 2003 Dec; 23(6):570-81. PubMed ID: 15094595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of fine-needle aspiration cytology and core biopsy in the diagnosis of proliferative and atypical breast lesions.
    Maygarden SJ
    Anat Pathol; 1997; 2():165-96. PubMed ID: 9575375
    [No Abstract]   [Full Text] [Related]  

  • 19. Atypical ductal hyperplasia: interobserver and intraobserver variability.
    Jain RK; Mehta R; Dimitrov R; Larsson LG; Musto PM; Hodges KB; Ulbright TM; Hattab EM; Agaram N; Idrees MT; Badve S
    Mod Pathol; 2011 Jul; 24(7):917-23. PubMed ID: 21532546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations].
    Dauplat MM; Penault-Llorca F
    Bull Cancer; 2004 Dec; 91 Suppl 4():S205-10. PubMed ID: 15899609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.